BVS Oct 2024 5.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
At close: 09:30AM EDT
Loading interactive chart...
- Zacks
Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner
Merck (MRK) exercises the option that will convert the collaboration deal with partner Orion for prostate cancer candidate opevesostat into a license agreement.
- Zacks
Here's Why You Should Consider Buying Bioventus (BVS) Stock
Here, we discuss some reasons why buying Bioventus (BVS) stock now may turn out to be a prudent move.
- Zacks
J&J (JNJ) Seeks Expanded Use of HIV Drug in US and Europe
J&J (JNJ) seeks expanded use of its HIV-1 therapy, Prezcobix, for younger kids in the United States and Europe.
© 2024 Yahoo. All rights reserved.